Gangrene
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D. [2]
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
Gangrene is a medical condition that involves necrosis and ischemia of a body tissue, mostly occurring in the digits or extremities. It usually appears as a black discoloration and sloughing of tissues. There are three main types of gangrene, namely wet gangrene, dry gangrene, and gas gangrene.
Historical Perspective
Gangrene originated from a Greek word that meant mortification of a human body part. It was first used as a noun in the British Isles during the 16th century. Surgeons most often used it to refer to the cure of external human conditions.
Classification
There are three main types of gangrene which include wet, dry, and gas gangrene. Sometimes it can be classified according to its site.
Pathophysiology
There are three types of gangrene and they have different pathophysiology. A reduced arterial perfusion is observed in dry gangrene which results in the compensatory arteriolar dilation, which eventually results in distal edema, and damage of the endothelial tissue. Saprogenic microorganisms such as Clostridium perfringens and Bacillus fusiformis are the most common organisms observed in wet gangrene which are responsible for infecting the tissues, thereby producing a putrid smell and edema. Group A Steptococcus and exotoxins from Clostridium perfringens are responsible for the local and systemic infection found in gas gangrene.
Causes
According to Hippocratic physicians, gangrene is brought about by three reasons. These include wound constriction that is followed by hemorrhage, body part compression, and necrosis due to bandages.
Differentiating Gangrene from other Diseases
Gangrene can have several mimicking conditions despite the unique presence of necrotic tissue.
Epidemiology and Demographics
Ischemic or dry gangrene is commonly associated with peripheral artery disease (PAD). The most advanced stage of PAD is critical limb ischemia/ chronic limb-threatening ischemia, and it has an incidence rate of 1% in the United States. Gas gangrene is a rare condition, with an annual record of 1000 cases in the United States, 50% of which are due to traumatic injuries, 30% due to post-operative complications, and the remaining part is attributed to infections.
Risk Factors
There are several risk factors for gangrene and these include penetrating trauma, blunt trauma, recent surgery, obesity, alcoholism, mucosal breach, skin breach, and immunosuppression.
Natural History, Complications, and Prognosis
Amputation and death are the most common consequence of critical limb ischemia/ chronic limb-threatening ischemia. Gas gangrene has higher fatality rate, ranging from 25% to 100%, if treatment is inadequate or delayed. Increased age, several comorbidities present, and involvement of trunk lead to a poor prognosis.
Diagnosis
History and Symptoms
Chronic limb pain is the usual chief complaint of patients who developed gangrene.
Physical Examination
Patients with gangrene may have varying presentations depending on the type of gangrene they have.
Laboratory Findings
Evaluation of patients with ischemic gangrene is more focused on targeting the risk factors which include hyperlipidemia, diabetes, and renal failure. Laboratory tests to deal with these risk factors are usually requested for ischemic gangrene. Wet gangrene and gas gangrene are assessed with the help of cultures.
X-ray
X-rays are utilized in the evaluation of gas gangrene to identify any present subcutaneous gas.
CT scan
Computed tomography (CT scan) with contrast is the best initial imaging test for gangrene.
MRI
Magnetic resonance imaging (MRI) is not so useful in the evaluation of gas gangrene. The presence of gas is not very well detected using this imaging modality.
Other Imaging Findings
Other recommended imaging tests to consider in the evaluation of gangrene include ultrasound, duplex ultrasound, computed tomography / (CT) angiography, digital subtraction angiography, and magnetic resonance angiography / (MRA).
Other Diagnostic Studies
There are some useful tools that were developed to assess the possibility of gangrene. These include the recent development of the Society of Vascular Surgery which is called WIfI which stands for wound, ischemia, foot infection, and the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score.
Treatment
Medical Therapy
Ischemic gangrene can be medically treated with angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, and antiplatelet drugs such as aspirin and clopidogrel. Wet gangrene and gas gangrene are treated with antibiotics which should cover microorganisms detected in culture of the specimen with gangrene.
Surgery
The goal of surgical treatment in gangrene is to achieve revascularization to alleviate pain and avoid limb loss.
Primary Prevention
Gas gangrene can be prevented by always monitoring the blood glucose levels and maintaining them within the normal range, and regular foot inspection, most especially in those patients with diabetes. Post-exposure prophylaxis may be needed by immunocompromised individuals if they were in close contact with patients with necrotizing infection due to Group A streptococcus. Droplet and contact precautions are warranted to these susceptible individuals.
Secondary Prevention
Early diagnosis and prompt medical and surgical treatment of gangrene are needed to prevent the rapid progression and worsening of the disease.
Cost-Effectiveness of Therapy
Gangrene is a potential life-threatening condition if not given prompt treatment. Although the incidence is just low, gangrene can generate a high healthcare cost.
Future or Investigational Therapies
A novel gene therapeutic approach is currently conducted to promote reperfusion and angiogenesis of ischemic tissues, which can help in limb salvage. Ongoing study on this approach is conducted on mice and it involves the intramuscular injection of adeno-associated virus/ (AAV) vector, and E-selectin.
References
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
Gangrene originated from a Greek word “sphacelus” that meant mortification of a human body part.[1][2] It was first used as a noun in the British Isles during the 16th century. Surgeons most often used it to refer to the cure of external human conditions. [2]
Historical Perspective
- Gangrene originated from a Greek word “sphacelus” that meant mortification of a human body part. [1][2]
- It was first used as a noun in the British Isles during the 16th century. [2]
- Surgeons most often used it to refer to the cure of external human conditions. [2]
- In the 17th century, this word was passed on from one person to another, until a metaphorical meaning was given by Shakespeare in Coriolanus:
"The service of the foote
Being once gangren'd, is not then respected
For what it was before." [2]
- Pathology became a new profession in the 19th century, and has made gangrene as a taxonomical umbrella with a myriad of species flourished.
- In 1915, gangrene was described by surgeon D’Arcy Power in his book Wounds of War:
The wound generally becomes more or less emphysematous and discharges a thin brownish, offensive fluid, which contains bubbles of gas... The ineffective process continues after death and the swelling may rapidly become so great as to make the corpse unrecognizable.
Some Personalities With Significant Historical Contribution to the Discovery of Gangrene
- Table 1 lists the famous people who had contracted gangrene.
| Name | Image | Description |
|---|---|---|
| Jean Baptiste Lully | ![]() (Image courtesy of Wikipedia) |
|
| French King Louis XIV | ![]() (Image courtesy of Wikipedia) |
|
| Sebald Justinus Brugmans | ![]() (Image courtesy of Wikipedia) |
|
| John M. Trombold |
| |
| Father Camille Bulcke | ![]() (Image courtesy of Wikipedia) |
References
- ↑ 1.0 1.1 Christopoulou-Aletra H, Papavramidou N (2009). “The manifestation of “gangrene” in the Hippocratic corpus”. Ann Vasc Surg. 23 (4): 548–51. doi:10.1016/j.avsg.2009.02.002. PMID 19540438.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 Lawrence C (2005). “Gangrene”. Lancet. 366 (9498): 1689. doi:10.1016/S0140-6736(05)67683-0. PMID 16291052.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
There are three types of gangrene and they have different pathophysiology. A reduced arterial perfusion is observed in dry gangrene which results in the compensatory arteriolar dilation , which eventually results in distal edema, and damage of the endothelial tissue. [1] Saprogenic microorganisms such as Clostridium perfringens and Bacillus fusiformis are the most common organisms observed in wet gangrene which are responsible for infecting the tissues, thereby producing a putrid smell and edema. [2] Group A Steptococcus and exotoxins from Clostridium perfringens are responsible for the local and systemic infection found in gas gangrene.[3]
Pathophysiology
There are three types of gangrene and they have different pathophysiology.
Dry Gangrene
- A reduced arterial perfusion is observed in dry gangrene which results in the compensatory arteriolar dilation, which eventually results in distal edema, and damage of the endothelial tissue. [1]
- It is a type of coagulative necrosis which occurs in ischemic tissue. Closing
</ref>missing for<ref>tag
Wet Gangrene
- Saprogenic microorganisms such as Clostridium perfringens and Bacillus fusiformis are the most common organisms observed in wet gangrene. They are responsible for infecting the tissues, thereby producing a putrid smell and edema. [2]
- The pooling and accumulation of blood in the affected tissue promotes proliferation of bacteria.
- An edematous, putrid, soft, and dark tissue is observed.[2]
Gas Gangrene
- Group A Steptococcus and exotoxins from Clostridium perfringens are responsible for the local and systemic infection found in gas gangrene. [3]
- Clostridium perfringens produces a Clostridium– lecithinase called Alpha-toxin that contributes to tissue necrosis and systemic hemolysis.[4][5]
- Rapid progression to shock is usually observed.
References
- ↑ 1.0 1.1 “StatPearls”. 2022. PMID 32809387 Check
|pmid=value (help). - ↑ 2.0 2.1 2.2 Al Wahbi A (2018). “Autoamputation of diabetic toe with dry gangrene: a myth or a fact?”. Diabetes Metab Syndr Obes. 11: 255–264. doi:10.2147/DMSO.S164199. PMC 5987754. PMID 29910628.
- ↑ 3.0 3.1 Lehner PJ, Powell H (1991). “Gas gangrene”. BMJ. 303 (6796): 240–2. doi:10.1136/bmj.303.6796.240. PMC 1670510. PMID 1884064.
- ↑ Yang Z, Hu J, Qu Y, Sun F, Leng X, Li H; et al. (2015). “Interventions for treating gas gangrene”. Cochrane Database Syst Rev (12): CD010577. doi:10.1002/14651858.CD010577.pub2. PMC 8652263 Check
|pmc=value (help). PMID 26631369. - ↑ Sakurai J, Nagahama M, Oda M (2004). “Clostridium perfringens alpha-toxin: characterization and mode of action”. J Biochem. 136 (5): 569–74. doi:10.1093/jb/mvh161. PMID 15632295.
Differentiating Gangrene from other Diseases
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
Gangrene can have several mimicking conditions despite the unique presence of necrotic tissue.
- Gangrene can have several mimicking conditions despite the unique presence of necrotic tissue.
- Table 1 outlines the various differential diagnosis for gangrene.
References
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
Ischemic or dry gangrene is commonly associated with peripheral artery disease (PAD). The most advanced stage of PAD is critical limb ischemia/ chronic limb-threatening ischemia, and it has an incidence rate of 1% in the United States. Gas gangrene is a rare condition, with an annual record of 1000 cases in the United States, 50% of which are due to traumatic injuries, 30% due to post-operative complications, and the remaining part is attributed to infections. [1]
Epidemiology and Demographics of Gangrene
- Ischemic or dry gangrene is commonly associated with peripheral artery disease (PAD).
- The most advanced stage of PAD is critical limb ischemia/ chronic limb-threatening ischemia, and it has an incidence rate of 1% in the United States. [1]
- Periperhal artery disease of the lower extremities has a prevalence rate of 200 million, with up to 10% of them have critical limb ischemia/ chronic limb-threatening ischemia. [1]
- If an asymptomatic PAD is left untreated, progression to critical limb ischemia/ chronic limb-threatening ischemia in five years. [1]
- Gas gangrene is a rare condition, with an annual record of 1000 cases in the United States, 50% of which are due to traumatic injuries, 30% due to post-operative complications, and the remaining part is attributed to infections. [1]
References
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
There are several risk factors for gangrene and these include penetrating trauma, blunt trauma, recent surgery, obesity, alcoholism, mucosal breach, skin breach, and immunosuppression. [1] [2] [3][4] [5] [6] [7] [8]
Risk Factors
There are several risk factors for gangrene and these include:
- Penetrating trauma
- Blunt trauma
- Minor laceration
- Recent surgery (urologic, colonic or gynecologic procedures).
- Obesity
- Alcoholism
- Mucosal breach (rectal fissures, hemorrhoids, episiotomy)
- Skin breach (insect bite, varicella lesion, injection drug use)
- Immunosuppression (cirrhosis, diabetes mellitus, HIV, etc.) [1] [2]
References
- ↑ 1.0 1.1 Stevens DL, Bryant AE (2017). “Necrotizing Soft-Tissue Infections”. N Engl J Med. 377 (23): 2253–2265. doi:10.1056/NEJMra1600673. PMID 29211672.
- ↑ 2.0 2.1 Anaya DA, Dellinger EP (2007). “Necrotizing soft-tissue infection: diagnosis and management”. Clin Infect Dis. 44 (5): 705–10. doi:10.1086/511638. PMID 17278065.
- ↑ 3.0 3.1 Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS; et al. (2005). “Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles”. N Engl J Med. 352 (14): 1445–53. doi:10.1056/NEJMoa042683. PMID 15814880.
- ↑ 4.0 4.1 Hasham S, Matteucci P, Stanley PR, Hart NB (2005). “Necrotising fasciitis”. BMJ. 330 (7495): 830–3. doi:10.1136/bmj.330.7495.830. PMC 556077. PMID 15817551.
- ↑ 5.0 5.1 Eneli I, Davies HD (2007). “Epidemiology and outcome of necrotizing fasciitis in children: an active surveillance study of the Canadian Paediatric Surveillance Program”. J Pediatr. 151 (1): 79–84, 84.e1. doi:10.1016/j.jpeds.2007.02.019. PMID 17586195.
- ↑ 6.0 6.1 Aebi C, Ahmed A, Ramilo O (1996). “Bacterial complications of primary varicella in children”. Clin Infect Dis. 23 (4): 698–705. doi:10.1093/clinids/23.4.698. PMID 8909829.
- ↑ 7.0 7.1 Beaudoin AL, Torso L, Richards K, Said M, Van Beneden C, Longenberger A; et al. (2014). “Invasive group A Streptococcus infections associated with liposuction surgery at outpatient facilities not subject to state or federal regulation”. JAMA Intern Med. 174 (7): 1136–42. doi:10.1001/jamainternmed.2014.1875. PMID 24861675.
- ↑ 8.0 8.1 Gupta Y, Chhetry M, Pathak KR, Jha RK, Ghimire N, Mishra BN; et al. (2016). “Risk Factors For Necrotizing Fasciitis And Its Outcome At A Tertiary Care Centre”. J Ayub Med Coll Abbottabad. 28 (4): 680–682. PMID 28586594.
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
Amputation and death are the most common consequence of critical limb ischemia/ chronic limb-threatening ischemia. [1] Gas gangrene has a higher fatality rate, ranging from 25% to 100%, if treatment is inadequate or delayed. Increased age, several comorbidities present, and involvement of trunk lead to a poor prognosis. [2]
Complications
- Amputation and death are the most common consequence of critical limb ischemia/ chronic limb-threatening ischemia. [1]
- Below-the-knee amputations lead to a higher ambulatory rate than above-the-knee amputations.[3]
Prognosis
- There is a possibility of recurrence of critical limb ischemia/ chronic limb-threatening ischemia.
- Follow-up after revascularization procedures is needed for at least two years.[4]
- Gas gangrene has higher fatality rate, ranging from 25% to 100%, if treatment is inadequate or delayed.
- Increased age, several comorbidities present, and involvement of trunk lead to a poor prognosis. [2]
References
- ↑ 1.0 1.1 Elsayed S, Clavijo LC (2015). “Critical limb ischemia”. Cardiol Clin. 33 (1): 37–47. doi:10.1016/j.ccl.2014.09.008. PMID 25439329.
- ↑ 2.0 2.1 Yang Z, Hu J, Qu Y, Sun F, Leng X, Li H; et al. (2015). “Interventions for treating gas gangrene”. Cochrane Database Syst Rev (12): CD010577. doi:10.1002/14651858.CD010577.pub2. PMC 8652263 Check
|pmc=value (help). PMID 26631369. - ↑ Landry GJ (2007). “Functional outcome of critical limb ischemia”. J Vasc Surg. 45 Suppl A: A141–8. doi:10.1016/j.jvs.2007.02.052. PMID 17544035.
- ↑ Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R; et al. (2019). “Global vascular guidelines on the management of chronic limb-threatening ischemia”. J Vasc Surg. 69 (6S): 3S–125S.e40. doi:10.1016/j.jvs.2019.02.016. PMC 8365864 Check
|pmc=value (help). PMID 31159978.
Diagnosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Related Chapters
Related Chapters
Template:Circulatory and respiratory system symptoms and signs
Template:Skin and subcutaneous tissue symptoms and signs Template:Nervous and musculoskeletal system symptoms and signs Template:Urinary system symptoms and signs Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:Speech and voice symptoms and signs Template:General symptoms and signs
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH




